Cycloastragenol
The astragalus compound behind commercial telomerase activators. One small randomized trial found changes in cardiovascular markers, but no human study has convincingly shown telomere lengthening or any anti-ageing outcome.
Where to buy
Ships to 180+ countries · welcome discount for new customers
Referral link — this site may earn a commission on purchases.
What the science says
- Telomerase activation and telomere length Limited evidence
The telomerase-activating effect is documented in cell culture; in animals, a randomized study of the branded TA-65 product in bird chicks found no increase in telomere length during development. Human telomere data come mostly from uncontrolled or industry-linked observations.
- Cardiovascular markers Limited evidence
A randomized controlled trial of TA-65 in patients with metabolic syndrome reported improvements in some cardiovascular markers such as HDL and glucose. It was a single small trial with surrogate endpoints and industry involvement.
- Anti-ageing effects on skin and bone Limited evidence
A 2026 review of Astragalus membranaceus summarizes potential anti-ageing and anticancer activity on skin and bone, based on preclinical work. No clinical trial supports these uses.
Dosage & safety
How to take it
Interactions
With medications
- immunosuppressants (ciclosporin, tacrolimus, azathioprine, mycophenolate)
Astragalus-derived preparations are immunostimulating and may work against the drug. do not combine without medical supervision
Well-established interactions only — this is not a complete list. Always tell your doctor and pharmacist what you take.
Frequently asked questions
Does cycloastragenol lengthen telomeres?
No human study has convincingly shown cycloastragenol lengthens telomeres; telomerase activation is documented in cell culture, and a TA-65 study in bird chicks found no increase in telomere length. The human telomere data are mostly uncontrolled or industry-linked, so the evidence is limited.
Does TA-65 have any proven benefits?
One small industry-involved randomized trial of TA-65 in metabolic syndrome reported improvements in some cardiovascular markers such as HDL and glucose. That single surrogate-marker trial is limited evidence, and no anti-ageing outcome has been shown.
How much cycloastragenol should I take?
The metabolic syndrome trial used 16 mg/day of branded TA-65, taken once daily. Generic cycloastragenol products list 5–25 mg/day, but their content is often unverified, so a third-party assay matters more than the label number.
Is cycloastragenol safe with a history of cancer?
Avoid cycloastragenol if you have a history of cancer: any telomerase activator could in theory help pre-malignant cells survive, which has not been shown but not excluded. Also avoid it in pregnancy, breastfeeding and with immunosuppressants, since astragalus is immunostimulating.
Scientific references
- TA-65, A Telomerase Activator improves Cardiovascular Markers in Patients with Metabolic Syndrome
- TA-65 does not increase telomere length during post-natal development in house sparrow chicks (Passer domesticus)
- Astragalus membranaceus Has Potential Anti-Aging and Anticancer Effects on Skin and Bone
Related in Longevity & antioxidants
- Beta-Carotene Limited evidence
- Vitamin E Limited evidence
- Astaxanthin Limited evidence
- Chaga Mushroom Limited evidence
- Olive Fruit Extract (Hydroxytyrosol) Limited evidence
- PQQ Limited evidence